Michiel van de Sande

61PUBLICATIONS
291CO-AUTHORS
Molecular targetsPredictive and prognostic markersOral and maxillofacial surgeryCancer therapy (excl. chemotherapy and radiation therapy)Orthopaedics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (61)

|Aug 26, 2026
Vimseltinib for patients with tenosynovial giant cell tumor: A multicenter, open-label, phase 2 trial.

|Aug 05, 2026
Accurate Prediction of Central Conventional Chondrosarcoma Risk and Outcome Using Methylation Profiling: CHROME.

|Jul 28, 2026
Bridging the Gap: Biological Reconstruction with Vascularised Fibula, Massive Allograft, or Capanna Technique After Intercalary Resection in Children and Young Adults with Lower Limb Bone Sarcoma.

|Jul 20, 2026
TANGENT study design: a phase III, randomized study of emactuzumab for the treatment of tenosynovial giant cell tumors.

|Jul 08, 2026
Watchful waiting versus methylprednisolone or polidocanol injections as treatment of simple bone cysts.

|Jun 06, 2026
Critical appraisal of patient-reported and clinician-reported outcome measures assessing functional outcomes in lower extremity bone sarcoma patients-a COSMIN-based systematic review.

Pageof 11

Frequent Collaborators

20 joint publications

Hans Gelderblom

13 joint publications

Judith V M G Bovée

7 joint publications

Marta Fiocco

6 joint publications

Lizz van der Heijden